Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kulkarni Samarth
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   208,122    

Indirect Shares

   200,000      
Direct Value   $11,704,781    

Indirect Value

   $11,248,000      
Total Shares   408,122      
Total Value   $22,952,781      


Crispr Therapeutics Ag $11,704,781 Crispr Therapeutics Ag $11,704,781
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
     0.0%
 -67.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Crispr Therapeutics Ag CRSP 2024-04-15 208,122 2024-04-15 200,000    Premium*  
* Premium Members only  

Records found :    113         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-05-19 4 OE $1.81 $7,796 D/D 4,307 175,833 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-05-20 4 OE $1.81 $19,354 D/D 10,693 182,219 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-06-01 4 OE $1.81 $31,268 D/D 17,275 188,801 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-12-10 4 OE $1.81 $36,200 D/D 20,000 189,189 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-12-29 4 OE $1.81 $24,978 D/D 13,800 182,989 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-01-15 4 OE $1.81 $36,200 D/D 20,000 202,989 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-10-15 4 OE $1.81 $59,730 D/D 33,000 219,932 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-12-20 4 OE $1.81 $32,128 D/D 17,750 279,085 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-12-06 4 OE $1.81 $105,402 D/D 58,233 369,111 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-06-15 4 OE $12.57 $377,100 D/D 30,000 217,719 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-08-04 4 OE $12.57 $18,855 D/D 1,500 189,219 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-08-05 4 OE $12.57 $358,245 D/D 28,500 216,219 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-06-29 4 OE $12.57 $314,250 D/D 25,000 315,279 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-07-27 4 OE $12.57 $374,918 D/D 25,000 315,279 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-08-29 4 OE $16.21 $405,250 D/D 25,000 315,279 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-09-28 4 OE $16.21 $405,250 D/D 25,000 315,279 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-24 4 AS $16.46 $57,619 D/D (3,500) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-26 4 AS $16.74 $54,816 D/D (3,275) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-27 4 AS $16.78 $37,023 D/D (2,206) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-25 4 AS $16.87 $86,290 D/D (5,115) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-21 4 AS $17.01 $51,033 D/D (3,000) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-20 4 AS $17.36 $48,621 D/D (2,800) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-19 4 AS $17.54 $129,754 D/D (7,258) 134,047 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       –      –    2017-12-01 4 A $19.12 $509,873 D/D 26,667 133,560 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-11-28 4 OE $19.12 $478,000 D/D 25,000 315,279 0 -
  113  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us